News

The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug ...
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug ...
Recent health headlines include FDA's eye safety concerns over GSK's cancer drug, escalating malnutrition rates in Gaza ...
The FDA is reevaluating GlaxoSmithKline’s blood cancer drug Blenrep following mixed results from two phase 3 trials and mounting concerns about eye-related side effects and dosing. The agency is ...
New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...
A common anti-nausea drug used during chemotherapy may do more than ease discomfort, it could help women with aggressive ...
Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...
The FDA already is scheduled to decide by Dec. 30 whether the same drug can be used by patients with hypercortisolism, also ...
Women in the UK who took the pregnancy drug Diethylstilbestrol - also known as DES or Stilbestrol - could be screened by the ...
Hydrogels could revolutionize cancer treatment by facilitating targeted drug delivery, reducing adverse effects, and ...
Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two ...